Jo Evans.

New Podcast: BTOG does … Tobacco Dependency in Lung Cancer.

Dr Emma O’Dowd talks to Professor Sanjay Agrawal.

Wherever you get your podcasts or listen online
btog.org/btog-podcasts/

#LCSM #LungCancer

MHRA authorises cancer treatment variation with an administration time of 3–5 minutes As with all products, the MHRA will keep its safety under close review.

Sub-cut Nivolumab is go!

www.gov.uk/government/n...

#LCSM @btog.bsky.social #Mesothelioma

@btog.bsky.social #Nostaligia

No, but we MUST fund it adequately. We are seeing many more patients and for longer without any additional resource. Burnout is real

Delighted to share that Debra our Chair has been elected President of Lung Cancer Europe.

She says, “As LuCE’s first patient President, I’m honoured to build on Anne-Marie’s leadership & continue strengthening the voice of people affected by #lungcancer across Europe.” #LCSM

Only 45% of eligible ALK+ #lungcancer patients in England got targeted treatment.

People well enough to benefit didn’t get the drugs they needed. This isn’t good enough. #LCSM

www.lungcanceraudit.org.uk/wp-content/u...

FLAURA2 regimen now reimbursed. I have some questions. Who needs chemo? Everyone? Selected pts? Access to other therapies - assume Impower150 not available to patient who have had Chemo-Osi?
Is chemo-Osi likely better than sequencing Osi-IMPOWER 150?

Lung cancer keeps getting more complex!

The NIHR Applied Research Collaborations (ARCs) April 2025 newsletter The national newsletter from across all the NIHR ARCs. In this edition: Electric scooter schemes may reduce bicycle collisions by 20%, NIHR Impact Prize winners, a cost-effective anti-bullying program...

Read the April roundup of top stories from all 15 NIHR ARCs across the country
👇
mailchi.mp/nihr/april-2...

Incuding the latest research, resources, blogs, awards, events, training & much more

Join here to get this monthly roundup sent directly to your inbox: tinyurl.com/ARCsnewsletter

Mr11 has gone to #Nando’s to celebrate last day of term with his mates… means I get to eat stuff he won’t! Boom! Winner, winner salmon dinner!!

They do?

Pondering posting this since yesterday…. Yet another PIP report request asking when my patient with advanced lung cancer with brain mets might expect to be better from brain mets… is it appropriate to suggest they refer themself for brain imaging? 😡🤬😡🤬😡🤬🤬🤬

Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target With the increasing use of next-generation sequencing (NGS) for genomic profiling of lung cancer, it has been estimated that up to 50 % of non-squamous non-small cell lung cancer (NSCLC) may harbor an...

New review on ADCs in #lungcancer
“These are now being explored in other oncogene-driven subsets, including ALK…”

Still early days—but could help when TKIs stop working. Worth watching #LCSM

www.cancertreatmentreviews.com/article/S030...

Important & moving words from our amazing Fundraising Trustee Callum, who lost his mum to ALK+ #lungcancer last March.

This September, he’s running 6 marathons in 6 days across 6 countries to raise global awareness for ALK+ lung cancer.

#ALKpositive #LungCancerAwareness #LCSM

BTOG 2025 events for your diary ...

BTOG/ @nlca-natcan.bsky.social State of the Nation Update Webinar – Thu 15 May

ASCO Update Webinar June (date TBC)

WCLC Update Webinar September (date TBC)

continued...

It happens to be the 30 year anniversary of my Oxford Medical School graduation this year. This cartoon from the time of life predicted as a new NHS graduate hit the mark.

Not sure whether to laugh or cry at this…

It’s definitely a little cry in the corner

In 2021 I assumed my cough was from allergies & my chest pressure was work stress.

It was stage 4 #lungcancer. An x-ray & biomarker testing saved my life. Had no idea that anyone can get lung cancer.

📺 interview from @younglungcancer.bsky.social 👉https://youtu.be/S50UEv81kS0?si=rixipm5FYbvOmpNx 🤍

Completely agree! We have some exceptional clinical nurse specialist with a host of different skills and strengths to add positivity to the patient pathway! Here’s to all our cancer CNS team! You are worth your weight in anti-PDL1/PD1 antibodies (ie > than gold)

@btog.bsky.social community, Assemble!

Now you can find the link to complete our @islb.info survey in the @oncoalert.bsky.social newsletter! 📨

It only takes 5 min to help us understand how LB 🩸 is reshaping clinical practice worldwide!

bit.ly/43JzN03

@christianrolfo.bsky.social @rolfolab.bsky.social @weoncologists.bsky.social

Unfortunately, my NIH grant (Columbia P50 center grant subcontract) was one of the awards terminated. A stop work order has been issued. We’re 8 months into the project— a community engaged study to ⬆️ 🫁 ca & CVD screening in nyc. I know many others affected as well. Hoping for reversal/resolution 😕

Redditch nurse dies after developing Covid-19 symptoms Julie Omar was a

On the 5th Anniversary of Covid, I’m thinking of all those who lost their lives, including my cousin Julie Omar (Nee Harris), whose only error was going to work…

www.bbc.co.uk/news/uk-engl...

I’m just updating some teaching slides for next week and it always hits me as almost new information when I remind myself many of the stats in Paramount were descriptive!

Caution with extrapolating data from completely different cohorts…. I personally hate pemetrexed (for renal issues and fatigue) and wonder what this data would look like in a predominantly Caucasian population? Before asking if pemetrexed maintenance has a role in the IO era…

My patient, no. But lives in London, so will be interesting to see if this plays out in a PM2.5 type mechanism. Time and science will hopefully tell all

But beware of the real world…. Potentially less fit patients as compared to the trial population #BTOG25

@annaminchom.bsky.social on newer small cell therapeutic strategies and management of CRS and ICANS as specific TRAEs With thought around timings of dose delivery and education of AOS teams and patients, safely deliverable within the NHS

#BTOG25

With the successful role out of the TLHC programme, we now have a growing cohort of stage 1 SCLC patients. Hopefully this will become even more common, and work needed to understand optimal patient management @drjnaidoo.bsky.social #BTOG25